Evidence for association of HLA-A2 allele with onset age of Alzheimer's disease

Neurology

Volumn 49, Issue 2, 1997, Pages 512-518

  Payami, H ^a,b   Schellenberg, G D ^d,e   Zareparsi, S ^a   Kaye, J ^b,c   Sexton, G J ^a   Head, M A ^a   Matsuyama, S S ⁱ   Jarvik, L F ⁱ   Miller, B ^j   McManus, D Q ^h   Bird, T D ^d,f   Katzman, R ^g   Heston, L ^d   Norman, D ^a   Small, G W ⁱ  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c PORTLAND VA MEDICAL CENTER   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j HARBOR UCLA MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; FEMALE; GENETIC ASSOCIATION; HLA SYSTEM; HLA TYPING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOMODULATION; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL;

EID: 0030816559     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.49.2.512     Document Type: Article

References (35)

1. Kamino K, Orr HT, Payami H, et al. Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region. Am J Hum Genet 1992;51:998-1014.
2. Schellenberg GD, Bird TD, Wijsman EM, et al. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science 1992;258:668-671.
3. Levy-Lahad E, Wasco W, Poorkaj P, et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995;269:973-977.
4. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA, 1993;90:1977-1981.
5. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-923.
6. Payami H, Kaye J, Heston LL, Bird TD, Schellenberg GD. Apolipoprotein E genotypes and Alzheimer's disease. Lancet 1993;342:738.
7. Bennett C, Crawford F, Osborne A, et al. Evidence that the APOE locus influences rate of disease progression in late onset familial Alzheimer disease but is not causative. Am J Med Genet 1995;60:1-6.
8. Farrer L, Cupples A, van Duijn C, et al. Apolipoprotein E genotype in patients with Alzheimer's disease: implications for the risk of dementia among relatives. Ann Neurol 1995;38:797-808.
9. Jarvik G, Larson E, Goddard K, Kukull W, Schellenberg G, Wijsman E. Influence of apolipoprotein E genotype on the transmission of Alzheimer disease in a community-based sample. Am J Hum Genet 1996;58:191-200.
10. Duara R, Barker WW, Lopez-Alberola R, et al. Alzheimer's disease: interaction of apolipoprotein E genotype, family history of dementia, gender, education, ethnicity, and age of onset. Neurology 1996;46:1575-1579.
11. Li G, Silverman J, Altsteil L, Haroutunian V, et al. Apolipoprotein E ε4 allele and familial risk in Alzheimer's disease. Genet Epidemiol 1996;13:285-298.
12. Parham P, Ohta T. Population biology of antigen presentation by MHC class I molecules. Science 1996;272:67-74.
13. McGeer PL, Rogers J, McGeer EG. Neuroimmune mechanisms in Alzheimer disease pathogenesis. Alzheimer Dis Assoc Disord 1994;8:149-158.
14. Breitner JC, Welsh KA, Helms MJ, et al. Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs. Neurobiol Aging 1995;16:523-530.
15. Payami H, Kaye J, Becker W, Norman D, Wetzsteon P. HLA-A2, or a closely linked gene, confers susceptibility to early onset sporadic Alzheimer's disease in men. Neurology 1991;41:1544-1548.
16. Small GW, Matsuyama SS. HLA-A2 as a possible marker for early-onset Alzheimer disease in men. Neurobiol Aging 1986;7:211-214.
17. Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojobori T. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. HLA 1991: Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Oxford: Oxford University Press, 1992:1065-1220.
18. Small GW, Ebeling SC, Matsuyama SS, et al. Variable association of HLA-A2 in men with early-onset Alzheimer disease. Neurobiol Aging 1991;12:375-377.
19. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
20. Mirra S, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486.
21. Payami H, Zareparsi S, Montee KR, et al. Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women. Am J Hum Genet 1996;58:803-811.
22. Jarvik LF, Matsuyama SS, Chui H, Scheibel A, Vinters HV. Autopsy diagnosis of Alzheimer disease: independent reviews and clinical implications. Int J Geriatr Psychiatry 1995;10:505-510.
23. Fernandez-Vena MA, Falco M, Sun Y, Statsney P. DNA typing for HLA class I alleles: I. Subsets of HLA-A2 and of-A28. Hum Immunol 1992;33:163-173.
24. Terasaki PI, Bernoco D, Park MS, Ozturk G, Iwaki Y. Microdroplet testing for HLA-A, -B, -C, and -D antigens. Am J Clin Pathol 1978;69:103-120.
25. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res 1990;31:545-548.
26. Rebeck GW, Peris TT, West HL, Sodhi P, Lipsitz LA, Hyman BT. Reduced apolipoprotein epsilon 4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals. Neurology 1994;44:1513-1516.
27. Yu CE, Payami H, Olson JM, et al. The apolipoprotein E/CI/CII gene cluster and late-onset Alzheimer disease. Am J Hum Genet 1994;54:631-642.
28. Corder EH, Saunders AM, Strittmatter WJ, et al. Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease. Neurology 1995;45:1323-1328.
29. Sobel E, Louhija J, Sulkava R, et al. Lack of association of apolipoprotein E allele epsilon 4 with late-onset Alzheimer's disease among Finnish centenarians. Neurology 1995;45:903-907.
30. Corder EH, Lannfelt L, Viitanen M, et al. Apolipoprotein E genotype determines survival in the oldest old (85 years or older) who have good cognition. Arch Neurol 1996;53:418-422.
31. Payami H, Grimslid H, Oken B, et al. A prospective study of cognitive health in elderly (Oregon Brain Aging Study): effects of family history and apolipoprotein E genotype. Am J Hum Genet 1997;60:948-956.
32. Blackwelder W, Mittal K, McNamara P, Payne F. Lack of association between HLA and age in an aging population. Tissue Antigens 1982;20:188-192.
33. Proust J, Moulias P, Fumeron F, et al. HLA and longevity. Tissue Antigens 1982;19:168-173.
34. Lagaay A, D'Amaro J, Ligthart G, Schreuder G, van Rood J, Hijmans W. Longevity and heredity in humans. Association with human leukocyte antigens phenotype. Ann NY Acad Sci 1991;621:78-89.
35. Rea I, Middleton D. Is the phenotypic combination A1B8Cw7DR3 a marker for male longevity? J Am Geriatr Soc 1994;42:978-983.